APA (7th ed.) Citation

Weiner, A. B., Proudfoot, J. A., Aker, M., Cardenas, M., Gonzalez, S., Kelly, E., . . . Marks, L. S. (2025). Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical Trial. JCO Precision Oncology, 9, 1. https://doi.org/10.1200/PO-25-00535

Chicago Style (17th ed.) Citation

Weiner, Adam B., et al. "Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical Trial." JCO Precision Oncology 9 (2025): 1. https://doi.org/10.1200/PO-25-00535.

MLA (9th ed.) Citation

Weiner, Adam B., et al. "Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical Trial." JCO Precision Oncology, vol. 9, 2025, p. 1, https://doi.org/10.1200/PO-25-00535.